Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
Skin microbiota predicts atopic dermatitis in infants
WASHINGTON — Atopic dermatitis can be predicted in children aged as young as 6 months with skin microbiome and metabolome signatures, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Ruxolitinib cream efficacious, safe in pediatric patients with atopic dermatitis
WASHINGTON — Ruxolitinib was efficacious and well tolerated in pediatric patients with mild to moderate atopic dermatitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Plant-based topical successfully targets both inflammation, bacteria in atopic dermatitis
MIAMI BEACH, Fla. — Zabalafin, a nonsteroidal topical, demonstrated efficacy in reducing inflammation and bacteria on the skin of children and adults with atopic dermatitis, according to interim data presented in a poster at Masters of Pediatric Dermatology.
Healthy teen awakens with lesions in early morning hours
A healthy, adolescent boy is seen for recurrently awakening with pruritic, urticarial-like lesions between his upper thighs extending to his mid-thorax.
When all else fails: Treating hyperhidrosis with endoscopic thoracic sympathectomy
It was just another day at school when sophomore Cole Villaflor and his classmates were asked to write on-demand essays in class. As he approached this seemingly easy assignment, his hands began to sweat, dampening the page.
Children, adolescents with difficult-to-control AD benefit from multidisciplinary approach
Children and adolescents with difficult-to-control atopic dermatitis can benefit from a multidisciplinary approach that combines the perspectives of dermatologists, allergists and family members, according to a study.
‘With great power comes great responsibility’: Boxed warnings in pediatric dermatology
MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.
Roflumilast foam outperforms vehicle in seborrheic dermatitis treatment
Phase 3 results that supported the approval of roflumilast foam 0.3% for seborrheic dermatitis treatment showed that the drug was superior to vehicle for individuals aged 9 years and older in this indication, according to a study.
Ycanth receives permanent J-code from CMS
Ycanth has received a permanent J-code from the Centers for Medicare & Medicaid Services, Verrica Pharmaceuticals announced in a press release.
Atopic dermatitis in children may be linked to metabolic syndrome, liver disease
Atopic dermatitis in children may be associated with metabolic syndrome and nonalcoholic fatty liver disease, according to a study.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read